Debbie Lawes


Organizations:
House of Commons Standing Committee, Innovative Medicines Canada, and Patented Medicines Prices Review Board

Topics:
COVID-19, drug prices, and Patented Medicine Regulations


Pharma companies urge Ottawa to postpone changes to lower drug prices to next year

Debbie Lawes
May 20, 2020

Innovative Medicines Canada warns critical research will be impacted if the government forces its members to implement required regulatory changes by July 1.

... Please become a Member or login to read the rest of this article ...


Other News

New micro-certification program could become model for upskilling workers

The Short Report, May 13, 2020: Public trust in science rising; new COVID-19 advisory councils created; OneEleven ceases operations; and more

New portal aims to accelerate procurement opportunities for Canadian firms

Alberta’s innovation community urges UCP government to act on expert panel’s report






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.